1. The concept of the metabolic, or insulin
resistance, syndrome (IRS) is currently being reappraised. How should it be
characterized?
a. The IRS is a newly recognized disease which, when
detected, should be treated with an insulin sensitizing agent.
b. The IRS should be considered a new term for the
pre-diabetic state, and when detected should lead to the initiation of
glucose-lowering medication.
c. The IRS represents an interrelated set of
conditions, which, when detected, should lead to heightened awareness of
the potential for development of a variety of related and seemingly
unrelated disease states, including diabetes, dyslipidemia, hypertension,
cardiovascular disease (CVD), non-alcoholic fatty liver disease (NAFLD),
polycystic ovary syndrome (PCOS), Alzheimer’s disease, sleep apnea
syndrome, and a number of malignancies.
2. Problems with the diagnosis of IRS include:
a. the profusion of proposed diagnostic criteria,
all identifying different populations of individuals with the syndrome
b. lack of evidence-that any proposed diagnostic criteria are actually
associated with CVD
c. the failure of any of the proposed definitions to lead to
identification of persons at increased risk of diabetes.
d. all of the above
e. none of the above
3. AMP kinase
is:
a. activated by elevations in intracellular ATP
b. activated by elevations in intracellular AMP
c. the enzyme which catalyzes the production of cyclic AMP from ATP
4. AMP activation:
a. is associated with caloric restriction and
exercise
b. can be induced pharmacologically with metformin, thiazolidinediones,
alpha-lipoic acid, estrogen, and polyphenols such as those found in red
wine.
c. decreases the inhibitory effect of malonyl co-A on mitochondrial fatty
acid metabolism
d. all of the above
e. none of the above
5. 11 β OH steroid dehydrogenase (11 βHSD)-type 2 converts cortisol to cortisone in the kidney, placenta, and colon, while 11 βHSD-type 1 has the opposite effect, by catalyzing conversion of cortisone to cortisol. All of the following are true about 11 βHSD1 EXCEPT:
a. a. is expressed in adipose tissue
b. is preferentially expressed in visceral as compared to subcutaneous
adipose tissue
c. increases intracellular cortisol levels
d. is decreased by a high fat diet
e. is downregulated in type 2 diabetes
6. Peroxisome proliferator-activated receptor (PPAR) γ Coactivator (PGC)-1, which also coactivates PPARα and hepatic nuclear factor-4, is reduced in all of the following EXCEPT:
a. administration of thiazolidinediones and
metformin
b. type 2 diabetes
c. insulin resistance in non-diabetic persons
d. low levels of physical activity
e. high fat feeding, particularly of saturated fats
7. Leptin acts in the brain to reduce food
intake, while states of low circulating leptin are associated with appetite
stimulation. What is the relationship of insulin levels to appetite
regulation?
a. a. insulin stimulates appetite, increasing food
intake
b. insulin reduces appetite, decreasing food intake
c. insulin has no effect at normal and high glucose levels on food intake,
only playing a role in appetite regulation under circumstances of
hypoglycemia
8. Insulin resistance is associated with the
following CNS abnormalities:
a. reduced effect of insulin in stimulating food
intake
b. reduced effect of insulin in suppressing food intake
c. neurodegenerative disorders such as Alzheimer’s disease
d. all of the above
e. “b” and “c” only
9. Hibernating mammals exhibit insulin
resistance as a means of:
a. regulating temperature
b. storing vast deposits of fat
c. decreasing metabolic rate
10. True of False: The nuclear regulatory factor rev-erbα is inversely related to PPARγ receptor activation.
a. True
b. False
11. Disruption of normal sleep-wake cycles is
associated with:
a. increased energy expenditure, resulting in
excessive weight loss
b. improvement in sleep-related disorders such as obstructive sleep apnea
c. obesity, diabetes, dyslipidemia, and hypertension
|